Article Details

Roche's ENSPRYNG approved by European Commission as first and only at-home subcutaneous ...

Retrieved on: 2021-06-28 06:00:00

Tags for this article:

Click the tags to see associated articles and topics

Roche's ENSPRYNG approved by European Commission as first and only at-home subcutaneous .... View article details on hiswai:

Excerpt

Roche's ENSPRYNG approved by European Commission as first and only at-home subcutaneous treatment for neuromyelitis optica spectrum disorder ( ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up